# Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication

> **NCT06811207** · PHASE3 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 300 (estimated)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Esomeprazole 40mg
- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT06811207
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2025-02-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06811207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06811207, "Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06811207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*